Tarbox Family Office, Inc. Bristol Myers Squibb CO Transaction History

Tarbox Family Office, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $50,470 - $55,586	-695 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $350,743 - $420,572	-5,705 Reduced 89.14%	695 $51,000
Q4 2021 Jan 06, 2022	SELL	$53.63 - $62.52 $5,523 - $6,439	-103 Reduced 1.58%	6,400 $399,000
Q2 2021 Jul 16, 2021	BUY	$61.91 - $67.42 $2,538 - $2,764	41 Added 0.63%	6,503 $435,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $178 - $200	-3 Reduced 0.05%	6,462 $408,000
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $3,579 - $4,056	-62 Reduced 0.95%	6,465 $401,000
Q3 2020 Oct 22, 2020	SELL	$57.43 - $63.64 $55,075 - $61,030	-959 Reduced 12.81%	6,527 $394,000
Q2 2020 Jul 23, 2020	BUY	$54.82 - $64.09 $14,033 - $16,407	256 Added 3.54%	7,486 $440,000
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $19,627 - $28,522	-423 Reduced 5.53%	7,230 $403,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $345,355 - $450,485	7,018 Added 1105.2%	7,653 $491,000
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $7,942 - $8,782	178 Added 38.95%	635 $29,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $1,353 - $1,614	-30 Reduced 6.16%	457 $22,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $5,948 - $7,714	-122 Reduced 20.03%	487 $25,000
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $1,263 - $1,574	-25 Reduced 3.94%	609 $34,000
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $599 - $653	10 Added 1.6%	634 $39,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $34,463 - $39,773	624	624 $40,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.